Results 191 to 200 of about 3,863,870 (310)

<p>Integrating Cybersecurity Frameworks (NIST and ISO/IEC 27001) into it Audit Practices: Evaluating the Effectiveness of Global Cybersecurity Frameworks in Strengthening Audit Outcomes</p>

Omotomiwa Omolere
openalex   +1 more source

Methodological Evaluation of Urban Primary Care Networks in Ethiopia Using Difference-in-Differences for Clinical Outcomes Measurement,

, 2009
Yemane Teshome, Mekonnen Abebaw
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Multi-level treatment outcome evaluation in adolescents with autism spectrum disorder. [PDF]

Child Adolesc Psychiatry Ment Health
Auer GA, Plener PL, Poustka L, Konicar L.   +3 more
europepmc   +1 more source

Outcome Evaluation of Burn Injury Management: A Study of Selective Traditional Home Remedies. [PDF]

Cureus, 2023
Alharbi Z, Farran E, Akbar J, Abid O, Albukhari Z.   +4 more
europepmc   +1 more source

Evaluation of Treatment Outcome in Gingival Hyperpigmentation with Scalpel Vis-a-Vis Laser

, 2021
Oliver Jacob, Manab Kosala, Mohinder Panwar   +2 more
openalex   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Outcome evaluation of a clinical nurse specialist continuing education pilot program: an intervention study with three repeated measures. [PDF]

BMC Nurs
Wright M, Kvist T, Mikkonen S, Jokiniemi K.   +3 more
europepmc   +1 more source

Epigenetic Applications in Adverse Outcome Pathways and Chemical Risk Evaluation [PDF]

, 2017
Allard, P, Angrish, M, Chadwick, LH, Chorley, BN, Hines, E, McCullough, SD   +5 more
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source